Neuropeptide Y Completed Phase 1 Trials for Post Traumatic Stress Disorder (PTSD)

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT01533519A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)